When a Facebook, Uber, or Airbnb of health care looks elusive

Okay, I used these big names in the headline to grab some attention. That said, few would disagree that there’s dire need for such unicorns to emerge in health care so that the benefits of network conditions make health care less expensive, more effective, and above all, participatory in managing chronic illnesses. One could argue […]

Bean counting is fine Mr Modi, but also look at the ‘blue sky’

Every once in a while comes a researcher who by the sheer intensity of his visceral interest in a phenomenon, or a nagging question, changes the course of a discipline. Psychiatrist and bioengineer at Stanford University Karl Deisseroth is one such scientist. Former IISc director P Balaram, while introducing him at the TNQ-Cell Press lecture last […]

Personalizing cancer care, one tumor at a time

When cancer knocks at one’s door, pretty much like a dreaded guest, one doesn’t know the extent of the dread immediately. As the guest settles in, the unpleasantness unravels. It’s somewhat similar feeling with cancer diagnosis. One doesn’t know if it’s a deadly form of cancer and in what stage; what will be the prognosis; […]

Can Strand-HCG alliance change the economics of cancer care in India?

  What does this say about cancer care when one of the foremost cancer specialists and promoter of the largest cancer hospital in the country says there’s much “wastage” in cancer treatment in the country?   To put it crudely, according BS AjaiKumar, “Of all the cancer cases we see, 33 percent are under treated, […]

BJP, Ayurgenomics, and the dangerous mixing of science & politics

Indian elections are insipid when it comes to debates and discussions around big, futuristic ideas. Neither political parties discuss their vision in any meaningful detail nor does the public ask for it. But a few days ago some publications picked up an exotic-sounding term, “Ayurgenomics”, from the BJP manifesto. It said:   “We will start […]

BJP, Ayurgenomics, and the dangerous mixing of science & politics

Indian elections are insipid when it comes to debates and discussions around big, futuristic ideas. Neither political parties discuss their vision in any meaningful detail nor does the public ask for it. But a few days ago some publications picked up an exotic-sounding term, “Ayurgenomics”, from the BJP manifesto. It said:   “We will start […]

Don't be Averse to Clinical Trials, Fix the System

A panel report, as reported in Mint today, shows the much suspected irregularities in the drug controller’s office. This specific committee report is about the drug approval process, but I want to raise a related issue here, of clinical trials. I know, given the herd mentality, a fresh backlash against clinical trials will begin in […]